ILNS

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 550 Sylvan Ave
  • Englewood Cliffs, NJ 07632

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2016 10-Q
CIK 0001337905
Fiscal Year End 6/30
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2005
Employees 1 a/o Oct 31, 2015
Company Officers/Contacts
Elliot M. Maza CEO, CFO
Company Directors
Elliot M. Maza Chairman
Isaac Onn Independent Director
Service Providers
Accounting/Auditing Firm
Paritz & Company, P.A.
15 Warren St.
Suite 25
Hackensack, NJ, 07601
United States
 
Securities Counsel
Sichenzia Ross Ference Kesner LLP OTCQX Sponsor
1185 Avenue of the Americas
37th Floor
New York, NY, 10036
United States
 
Investor Relations Firm
ILNS Security Details
Share Structure
Market Value1 $288,201 a/o Oct 18, 2017
Authorized Shares 2,000,000,000 a/o Nov 04, 2015
Outstanding Shares 6,520,389 a/o May 09, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 4,717,663 a/o Nov 04, 2015
Par Value Not Available
Shareholders
Shareholders of Record 202 a/o Nov 04, 2015
Short Selling Data
Short Interest 6,672 (0%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security